InvestorsHub Logo
Followers 9
Posts 627
Boards Moderated 0
Alias Born 06/22/2007

Re: Jasbg post# 298079

Thursday, 09/10/2020 3:43:20 PM

Thursday, September 10, 2020 3:43:20 PM

Post# of 425931
Jas theoretically the FDA has to approve their ads but the reality is that Amarin already won the right to market truthful information in court. That rule is hollow and the FDA hates AMRN anyway (because of that very free speech suit) hence the surprise ad-com which delayed our insurance coverage and their immediate grant of a label to Hikma. The FDA's rule would be held to be in violation and the settlement if they tried to enforce it.

The whole point of the free speech suit was to be able to run Reduce-IT ads on day one.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News